International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

• Published in: Annals of oncology Vol. 22; no. 3; pp. 515 - 523
• Main Authors: Dawood, S., Merajver, S.D., Viens, P., Vermeulen, P.B., Swain, S.M., Buchholz, T.A., Dirix, L.Y., Levine, P.H., Lucci, A., Krishnamurthy, S., Robertson, F.M., Woodward, W.A., Yang, W.T., Ueno, N.T., Cristofanilli, M.
• Format: Journal Article
• Language: English
• Published: Oxford Elsevier Ltd 01-03-2011; Oxford University Press
• Subjects: Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized; Antineoplastic agents; Antineoplastic Agents - therapeutic use; Aromatase Inhibitors - therapeutic use; Biological and medical sciences; Biomarkers, Tumor - metabolism; Diagnostic Techniques and Procedures; Female; guidelines; Gynecology. Andrology. Obstetrics; Humans; inflammatory breast cancer; Inflammatory Breast Neoplasms - diagnosis; Inflammatory Breast Neoplasms - therapy; Mammary gland diseases; management; Medical sciences; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Pharmacology. Drug treatments; Radiotherapy, Adjuvant; Receptor, ErbB-2 - metabolism; Receptors, Estrogen - metabolism; Receptors, Progesterone - metabolism; Reviews; Tamoxifen - therapeutic use; Trastuzumab; Tumors; management; guidelines; inflammatory breast cancer; Breast disease; Breast cancer; Inflammation; Malignant tumor; Management; Consensus; Recommendation; Mammary gland diseases; Clinical management; Treatment; Diagnosis; Cancer; International
• ISSN: 0923-7534; 1569-8041
• DOI: 10.1093/annonc/mdq345

Inflammatory breast cancer (IBC) represents the most aggressive presentation of breast cancer. Women diagnosed with IBC typically have a poorer prognosis compared with those diagnosed with non-IBC tumors. Recommendations and guidelines published to date on the diagnosis, management, and follow-up of women with breast cancer have focused primarily on non-IBC tumors. Establishing a minimum standard for clinical diagnosis and treatment of IBC is needed.
Recognizing IBC to be a distinct entity, a group of international experts met in December 2008 at the First International Conference on Inflammatory Breast Cancer to develop guidelines for the management of IBC.
The panel of leading IBC experts formed a consensus on the minimum requirements to accurately diagnose IBC, supported by pathological confirmation. In addition, the panel emphasized a multimodality approach of systemic chemotherapy, surgery, and radiation therapy.
The goal of these guidelines, based on an expert consensus after careful review of published data, is to help the clinical diagnosis of this rare disease and to standardize management of IBC among treating physicians in both the academic and community settings.